Tom Denison (@tomdenison) 's Twitter Profile
Tom Denison

@tomdenison

Tom Denison wallows in happiness, elegant simplicity and fatherhood. My passion is building biotech startups.

ID: 15020415

linkhttps://about.me/tom.denison calendar_today05-06-2008 17:01:36

14,14K Tweet

1,1K Followers

1,1K Following

Tom Denison (@tomdenison) 's Twitter Profile Photo

‘A Great Formula for Success’: Booth Alum Jennifer Fried Named CEO of Another UChicago Startup - Polsky Center for Entrepreneurship and Innovation buff.ly/3sUmDNv

Tom Denison (@tomdenison) 's Twitter Profile Photo

Saros Therapeutics, a SmartHealth Catalyzer Portfolio Company, Receives $2 Million Direct-to-Phase 2 SBIR Grant from the National Cancer Institute to Advance STING Agonist Program buff.ly/3ZtX2XU

Saros Therapeutics, a SmartHealth Catalyzer Portfolio Company,  Receives $2 Million Direct-to-Phase 2 SBIR Grant from the National Cancer Institute to Advance STING Agonist Program  buff.ly/3ZtX2XU
Tom Denison (@tomdenison) 's Twitter Profile Photo

A multi-institutional team of researchers, including Northwestern University scientists, received $45 million from the Advanced Research Projects Agency for Health (ARPA-H) to fast-track development of a first-of-its-kind implant to sense and treat cancer buff.ly/3RCuXM1

Tom Denison (@tomdenison) 's Twitter Profile Photo

Evozyne Announces $81 Million Financing Round to Advance Generative AI for Therapeutic Discovery and Drug Development buff.ly/3LEmqEG

Evozyne Announces $81 Million Financing Round to Advance Generative AI for Therapeutic Discovery and Drug Development  buff.ly/3LEmqEG
Tom Denison (@tomdenison) 's Twitter Profile Photo

Announcing the Close of 7wireVentures’ Newest Investment Vehicle: A $217M + Growth & Opportunity Fund - 7wireVentures buff.ly/45eaPmF

Tom Denison (@tomdenison) 's Twitter Profile Photo

Rhaeos, Inc. Receives $1.5 Million Blueprint MedTech Grant from the NIH to Transform Hydrocephalus Management buff.ly/48KjwrU

Chicago Biomedical Consortium (@chibiomed) 's Twitter Profile Photo

We are proud to announce our 3rd speaker of the day: Dr. Anil Vasudevan, Executive Director of AbbVie, who will discuss developing early-stage assets. Register for our afternoon session (2pm – 6pm): cbc-venture-capital.eventbrite.com Tickets will be released to waitlist on Mon, Oct 30

We are proud to announce our 3rd speaker of the day: Dr. Anil Vasudevan, Executive Director of
<a href="/abbvie/">AbbVie</a>, who will discuss developing early-stage assets.

Register for our afternoon session (2pm – 6pm): cbc-venture-capital.eventbrite.com
Tickets will be released to waitlist on Mon, Oct 30
Tom Denison (@tomdenison) 's Twitter Profile Photo

Chicago Biomedical Consortium Secures $13.5 Million to Scale Work, Support for Life Sciences Industry - Polsky Center for Entrepreneurship and Innovation buff.ly/3FyMP3f

David Pepper (@davidpepper) 's Twitter Profile Photo

Steubenville, Manchester and democracy A 🧵 Last night, PBS and the iconic Judy Woodruff aired a story about the plight of Steubenville, Ohio. You should watch it. All of Ohio should. (Link below): It’s the story of Ohio that state leaders don’t want told. 1/

Steubenville, Manchester and democracy 

A 🧵 

Last night, PBS and the iconic Judy Woodruff aired a story about the plight of Steubenville, Ohio. You should watch it. All of Ohio should.

(Link below):

It’s the story of Ohio that state leaders don’t want told.

1/